Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
nocloprost novel
4
novel prostanglandin
4
prostanglandin analog
4
analog reduction
4
reduction aspirin
4
aspirin induced
4
induced grastrointestinal
4
grastrointestinal lesions
4
lesions man
4
nocloprost
1
Similar Publications
Novel therapeutic approaches to gastric and duodenal ulcers: an update.
Expert Opin Investig Drugs
July 2000
International Drug Development Consultants Corporation, 1549 RFD, Long Grove, IL 60047-9532, USA.
Over the last 25 years, a remarkable revolution in the pathophysiology and treatment of gastric and duodenal ulcers has occurred. Effective therapies were developed not only to heal ulcers, but also to cure most patients. The two principal causes for gastric and duodenal ulcers are either infection with Helicobacter pylori or the use of non-steroidal anti-inflammatory drugs (NSAIDs).
View Article and Find Full Text PDFNocloprost, a novel prostanglandin E2 analog: significant reduction of aspirin induced grastrointestinal lesions in man.
Prog Clin Biol Res
December 1987
Krankenhaus Bethanien, Hamburg, F.R.G.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!